Clinical trials may eventually be used to formally test the value of PRSs in combination with appropriate clinical variables. The model might be similar to that used in recent trials using pharmacogenetic testing (67), although appropriate follow-up would presumably be more extended. This would provide an opportunity for real-life examination of the feasibility and utility of such scores. Appropriate clinician training would be an essential part of such trials.
